基于“互联网+”技术的上海市质子重离子医院资产管理的 探索和实践

针对医院资产管理的现状和难点,将平台中的空间管理同资产管理相结合,进行数据交互和功能拓展,不仅使医院空间和资产同步系统化、数据化,而且汇聚了资产管理全维度数据源,达到优化资源配置、降本增效的实践成果,也为建立基于云数据的资产设备全生命周期管理夯实基础。     

CT诊断输尿管梗阻病因分析

目的　探讨CT诊断输尿管梗阻病因的价值。方法　本文收集 17例经多种泌尿系统的检查而未能确诊病因的资料。其中 ,12例经手术病理证实 ,2例经体外震波碎石治疗 ,3例经临床随访证实。结果　单纯性结石 5例 ,炎性狭窄 4例 ,乳头状移行细胞癌 2例 ,输尿管慢性炎症伴结石 1例 ,黄色肉芽肿性慢性肾盂肾炎伴结石 1例 ,右侧异位输尿管开口伴囊肿结石 1例 ,多囊肾伴左肾盂输尿管交界处狭窄 1例 ,左输尿管结核1例 ,乳房癌、直肠癌转移 /或侵犯输尿管各 1例。定位诊断率 10 0 % ,定性诊断率 88 2 4 %。结论　CT做为输尿管梗阻常规检查后的补充检查手段能有效提高病因诊断的正确率。     

Effect of Bmk venom microinjected into LS on electric activities of nociceptive neurons in Pf of rat

目的 :研究外侧隔核是否是蝎毒产生中枢镇痛作用的重要部分之一。方法 :用玻璃微电极记录束旁核的单位放电 ;通过不锈钢套管向外侧隔核内微量注射 0 .0 3%蝎毒。结果 :外侧隔核内微量注射0 .0 3%蝎毒可以明显地减弱束旁核内的痛兴奋神经元和痛抑制神经元对伤害性刺激的反应。结论 :外侧隔核是蝎毒产生中枢镇痛作用的重要部位之一。     

等长收缩运动中血浆内啡呔的检测及评价

目的观察健康青年人在等长收缩运动(IE)时血浆内啡肽(EOPs)的变化.方法选择健康自愿受试者40例,男女各20例,平均年龄(23.7±2.9)岁,研究设置二种模型即主观运动和被动运动.观察指标包括血浆中的亮氨酸脑啡肽(LEK)、β-内啡呔(β-END)和强啡呔(DYN).结果LEK、β-END、DYN在IE中均有不同程度的变化.结论在IE中LEK、DYN的变化程度较β-END明显(P＜0.01).     

动态增强磁共振成像在评估女性乳房乳头乳晕血供的应用

目的探究动态增强磁共振成像(DCE-MRI)用于评估女性乳房乳头乳晕血供特点的可行性,为乳房整形手术提供乳头乳晕的血供参考。方法从2012年3月至2019年10月华中科技大学同济医学院附属同济医院影像数据库中收集女性乳腺DCE-MRI图像资料,选择未发现肿物的正常乳房的DCE-MRI图像进行研究。在西门子工作站将患者乳腺DCE-MRI图像通过图像减影获取乳房血管图像,分别对轴位、冠状位和矢状位的最大密度投影(MIP)图像进行评估,结合三维MIP图像识别所有供应乳头乳晕的血管。乳头乳晕的血供被划分为内上、内侧、内下、外上、外侧、外下、中央、上方和下方9个象限,对各个象限血管进行统计和分析,并测量血管至乳房皮肤表面投影的最大距离。采用SPSS 19.0软件进行统计分析,通过卡方检验分别比较左侧与右侧乳房的乳头乳晕复合体(NAC)血供象限分布构成比。计算血管到皮肤距离的平均值、标准差及95%置信区间,通过方差分析比较各象限血管至皮肤距离的差异。P<0.05为差异具有统计学意义。结果共收集到245例患者490只女性乳房DCE-MRI图像,其中97例患者97只乳房发现有乳腺肿物,其余393只为正常乳房(97例单侧乳房、148例双侧乳房),将其作为研究对象。患者年龄23~72岁,平均43.7岁。393只乳房(左侧200只、右侧193只)共发现有637条(左侧311条、右侧326条)乳头乳晕供应血管。在637条血管中,内上象限269条(42.2%),外上180条 (28.3%),内侧57条(8.9%),下方37条(5.8%),中央30条(4.7%),内下25条(3.9%),外下25条(3.9%),上方11条(1.7%),外侧3条(0.5%)。卡方检验表明左侧乳房和右侧乳房在NAC血供象限分布构成比差异无统计学意义(χ2 =6.4,P=0.602)。除中央象限血管以外,所有血管到皮肤表面投影最大距离的平均值为0.91 cm, 95%置信区间为0.86~0.96 cm。方差分析表明各象限供血血管到皮肤投影的最大距离,差异有统计学意义(F=11.4,P<0.001)。结论 DCE-MRI可以清晰地显示乳头乳晕的血供来源。乳头乳晕血供主要来源于内上象限和外上象限的血管,血管在皮下约1 cm深度走行。     

Culture-Expanded Autologous Adipose-Derived Mesenchymal Stem Cell Treatment for Osteonecrosis of the Femoral Head

BackgroudOutcomes of traditional treatment for osteonecrosis of the femoral head (ONFH) are not always satisfactory. Hence, cell-supplementation therapy has been attempted to facilitate necrotic-tissue regeneration. Adipose-derived mesenchymal stem cell (ADMSC) transplantation is potentially advantageous over bone marrow-derived MSC implantation, but its outcomes for ONFH remain unclear. The aim of this study was to determine 2-year radiological and clinical outcomes of culture-expanded autologous ADMSC implantation for ONFH.MethodsEighteen hips with necrotic lesions involving ≥ 30% of the femoral head were included. ADMSCs were harvested by liposuction and culture expanded for 3 passages over 3 weeks. With a 6-mm single drilling, ADMSCs were implanted into the necrotic zone. All patients underwent magnetic resonance imaging (MRI), single-photon emission computed tomography/computed tomography (SPECT/CT) at screening and 6 months, 12 months, and 24 months postoperatively. The primary outcome was the change in the size of necrotic area on MRI. Secondary outcomes were changes in clinical scores and radioisotope uptake on SPECT/CT. Conversion total hip arthroplasty (THA) was defined as the endpoint.ResultsPreoperatively, the necrotic lesion extent was 63.0% (38.4%–96.7%) of the femoral head. The mean Harris hip score was 89.2, the University of California at Los Angeles (UCLA) score was 5.6, and Western Ontario and McMaster Universities Arthritis index (WOMAC) was 79.4. Three patients underwent THA and 1 patient died in an accident. Finally, 11 patients (14 hips) were available for ≥ 2-year follow-up. At the last follow-up, no surgery-related complications occurred, and 14 of 17 hips (82%) were able to perform daily activities without THA requirement. There was no significant decrease in lesion size between any 2 intervals on MRI. However, widening of high signal intensity bands on T2-weighted images inside the necrotic lesion was observed in 9 of 14 hips (64%); 11 of 14 hips (79%) showed increased vascularity on SPECT/CT at 2 years postoperatively. No significant differences were observed between preoperative and 24-month mean Harris hip score (89.2 vs. 88.6), WOMAC (79.4 vs. 75.7), and UCLA score (5.6 vs. 6.2).ConclusionsOur outcomes suggest that culture-expanded ADMSC implantation is a viable option for ONFH treatment without adverse events.